6533b86dfe1ef96bd12caa55

RESEARCH PRODUCT

Sympathetic activation in patients with heart failure and central sleep apnoea: is it friend or foe?

Maria R. BonsignoreMaria Teresa La Rovere

subject

Pulmonary and Respiratory MedicineSettore MED/10 - Malattie Dell'Apparato RespiratorioAutonomic function autoservoventilation prognosis

description

This sub-study of the SERVE-HF study found unchanged peripheral nervous sympathetic activity (MSNA) in heart failure patients on medical treatment or on ASV after 12 weeks. Reduced MSNA was associated with worse prognosis only in the ASV group

10.1183/13993003.02170-2022https://hdl.handle.net/10447/582476